Cargando…
Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis
Dynamin GTPase activity increases when it oligomerizes either into helices in the presence of lipid templates or into rings in the presence of SH3 domain proteins. Dynasore is a dynamin inhibitor of moderate potency (IC(50) ˜ 15 μM in vitro). We show that dynasore binds stoichiometrically to deterge...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons A/S
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138991/ https://www.ncbi.nlm.nih.gov/pubmed/24025110 http://dx.doi.org/10.1111/tra.12119 |
_version_ | 1782331307536154624 |
---|---|
author | McCluskey, Adam Daniel, James A. Hadzic, Gordana Chau, Ngoc Clayton, Emma L. Mariana, Anna Whiting, Ainslie Gorgani, Nick N. Lloyd, Jonathan Quan, Annie Moshkanbaryans, Lia Krishnan, Sai Perera, Swetha Chircop, Megan von Kleist, Lisa McGeachie, Andrew B. Howes, Mark T. Parton, Robert G. Campbell, Michael Sakoff, Jennette A. Wang, Xuefeng Sun, Jian‐Yuan Robertson, Mark J. Deane, Fiona M. Nguyen, Tam H. Meunier, Frederic A. Cousin, Michael A. Robinson, Phillip J. |
author_facet | McCluskey, Adam Daniel, James A. Hadzic, Gordana Chau, Ngoc Clayton, Emma L. Mariana, Anna Whiting, Ainslie Gorgani, Nick N. Lloyd, Jonathan Quan, Annie Moshkanbaryans, Lia Krishnan, Sai Perera, Swetha Chircop, Megan von Kleist, Lisa McGeachie, Andrew B. Howes, Mark T. Parton, Robert G. Campbell, Michael Sakoff, Jennette A. Wang, Xuefeng Sun, Jian‐Yuan Robertson, Mark J. Deane, Fiona M. Nguyen, Tam H. Meunier, Frederic A. Cousin, Michael A. Robinson, Phillip J. |
author_sort | McCluskey, Adam |
collection | PubMed |
description | Dynamin GTPase activity increases when it oligomerizes either into helices in the presence of lipid templates or into rings in the presence of SH3 domain proteins. Dynasore is a dynamin inhibitor of moderate potency (IC(50) ˜ 15 μM in vitro). We show that dynasore binds stoichiometrically to detergents used for in vitro drug screening, drastically reducing its potency (IC(50) = 479 μM) and research tool utility. We synthesized a focused set of dihydroxyl and trihydroxyl dynasore analogs called the Dyngo™ compounds, five of which had improved potency, reduced detergent binding and reduced cytotoxicity, conferred by changes in the position and/or number of hydroxyl substituents. The Dyngo compound 4a was the most potent compound, exhibiting a 37‐fold improvement in potency over dynasore for liposome‐stimulated helical dynamin activity. In contrast, while dynasore about equally inhibited dynamin assembled in its helical or ring states, 4a and 6a exhibited >36‐fold reduced activity against rings, suggesting that they can discriminate between helical or ring oligomerization states. 4a and 6a inhibited dynamin‐dependent endocytosis of transferrin in multiple cell types (IC(50) of 5.7 and 5.8 μM, respectively), at least sixfold more potently than dynasore, but had no effect on dynamin‐independent endocytosis of cholera toxin. 4a also reduced synaptic vesicle endocytosis and activity‐dependent bulk endocytosis in cultured neurons and synaptosomes. Overall, 4a and 6a are improved and versatile helical dynamin and endocytosis inhibitors in terms of potency, non‐specific binding and cytotoxicity. The data further suggest that the ring oligomerization state of dynamin is not required for clathrin‐mediated endocytosis. |
format | Online Article Text |
id | pubmed-4138991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | John Wiley & Sons A/S |
record_format | MEDLINE/PubMed |
spelling | pubmed-41389912014-09-22 Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis McCluskey, Adam Daniel, James A. Hadzic, Gordana Chau, Ngoc Clayton, Emma L. Mariana, Anna Whiting, Ainslie Gorgani, Nick N. Lloyd, Jonathan Quan, Annie Moshkanbaryans, Lia Krishnan, Sai Perera, Swetha Chircop, Megan von Kleist, Lisa McGeachie, Andrew B. Howes, Mark T. Parton, Robert G. Campbell, Michael Sakoff, Jennette A. Wang, Xuefeng Sun, Jian‐Yuan Robertson, Mark J. Deane, Fiona M. Nguyen, Tam H. Meunier, Frederic A. Cousin, Michael A. Robinson, Phillip J. Traffic Original Articles Dynamin GTPase activity increases when it oligomerizes either into helices in the presence of lipid templates or into rings in the presence of SH3 domain proteins. Dynasore is a dynamin inhibitor of moderate potency (IC(50) ˜ 15 μM in vitro). We show that dynasore binds stoichiometrically to detergents used for in vitro drug screening, drastically reducing its potency (IC(50) = 479 μM) and research tool utility. We synthesized a focused set of dihydroxyl and trihydroxyl dynasore analogs called the Dyngo™ compounds, five of which had improved potency, reduced detergent binding and reduced cytotoxicity, conferred by changes in the position and/or number of hydroxyl substituents. The Dyngo compound 4a was the most potent compound, exhibiting a 37‐fold improvement in potency over dynasore for liposome‐stimulated helical dynamin activity. In contrast, while dynasore about equally inhibited dynamin assembled in its helical or ring states, 4a and 6a exhibited >36‐fold reduced activity against rings, suggesting that they can discriminate between helical or ring oligomerization states. 4a and 6a inhibited dynamin‐dependent endocytosis of transferrin in multiple cell types (IC(50) of 5.7 and 5.8 μM, respectively), at least sixfold more potently than dynasore, but had no effect on dynamin‐independent endocytosis of cholera toxin. 4a also reduced synaptic vesicle endocytosis and activity‐dependent bulk endocytosis in cultured neurons and synaptosomes. Overall, 4a and 6a are improved and versatile helical dynamin and endocytosis inhibitors in terms of potency, non‐specific binding and cytotoxicity. The data further suggest that the ring oligomerization state of dynamin is not required for clathrin‐mediated endocytosis. John Wiley & Sons A/S 2013-11-11 2013-10-09 /pmc/articles/PMC4138991/ /pubmed/24025110 http://dx.doi.org/10.1111/tra.12119 Text en © 2013 The Authors. Traffic Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles McCluskey, Adam Daniel, James A. Hadzic, Gordana Chau, Ngoc Clayton, Emma L. Mariana, Anna Whiting, Ainslie Gorgani, Nick N. Lloyd, Jonathan Quan, Annie Moshkanbaryans, Lia Krishnan, Sai Perera, Swetha Chircop, Megan von Kleist, Lisa McGeachie, Andrew B. Howes, Mark T. Parton, Robert G. Campbell, Michael Sakoff, Jennette A. Wang, Xuefeng Sun, Jian‐Yuan Robertson, Mark J. Deane, Fiona M. Nguyen, Tam H. Meunier, Frederic A. Cousin, Michael A. Robinson, Phillip J. Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis |
title | Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis |
title_full | Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis |
title_fullStr | Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis |
title_full_unstemmed | Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis |
title_short | Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis |
title_sort | building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138991/ https://www.ncbi.nlm.nih.gov/pubmed/24025110 http://dx.doi.org/10.1111/tra.12119 |
work_keys_str_mv | AT mccluskeyadam buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT danieljamesa buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT hadzicgordana buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT chaungoc buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT claytonemmal buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT marianaanna buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT whitingainslie buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT gorganinickn buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT lloydjonathan buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT quanannie buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT moshkanbaryanslia buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT krishnansai buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT pereraswetha buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT chircopmegan buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT vonkleistlisa buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT mcgeachieandrewb buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT howesmarkt buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT partonrobertg buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT campbellmichael buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT sakoffjennettea buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT wangxuefeng buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT sunjianyuan buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT robertsonmarkj buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT deanefionam buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT nguyentamh buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT meunierfrederica buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT cousinmichaela buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis AT robinsonphillipj buildingabetterdynasorethedyngocompoundspotentlyinhibitdynaminandendocytosis |